Pfizer-BioNTech is sending mixed messages about COVID-19 vaccine shipments to Canada, telling Ottawa there will be a delay in deliveries, despite the drug company ramping up its manufacturing capacity in Europe. David Akin reports.
- Ramp up Canadian vaccine manufacturing capacity: Coronavirus task force health adviser
- Guelph’s COVID-19 vaccination plan changes due to Pfizer production delay
- First Moderna COVID-19 vaccines arrive in Guelph area